OVERALL SURVIVAL

Clinical trials for OVERALL SURVIVAL explained in plain language.

Never miss a new study

Get alerted when new OVERALL SURVIVAL trials appear

Sign up with your email to follow new studies for OVERALL SURVIVAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Completed 2

New cocktail of drugs shows promise against rare lymphoma

Disease control Not yet recruiting

This study is testing a combination of three drugs—sintilimab, chidamide, and azacitidine—as a first treatment for people with early-stage extranodal NK/T-cell lymphoma, a rare blood cancer. About 30 participants will receive the drugs, and their response will guide further treat…

Matched conditions: OVERALL SURVIVAL

Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

OVERALL SURVIVAL

Get alerted when new OVERALL SURVIVAL trials appear

New cocktail of drugs shows promise against rare lymphoma